...
首页> 外文期刊>BMC Genomics >Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants
【24h】

Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants

机译:牛津纳米孔技术适应丙型肝炎的全基因组测序和宿主病毒变体内的鉴定

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here ‘nanopore sequencing’) has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~?1800?nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing.
机译:丙型肝炎(HCV)和许多其他RNA病毒存在于单个感染宿主中的迅速突变的准物种群体。尽管下一代测序的进步,但是仍然不可能实现全基因组的高吞吐量表征。该限制限制了依赖于精确鉴定半基因组或全基因组的病毒基因组研究,尤其是在低频下发生的宿主变体。随着第三代长度读取测序技术的出现,包括牛津纳米孔技术(ONT)和PACBIO平台,这个问题可能是普及的。由于碎序列序列器的便携性性质,在这方面特别有吸引力,这使得在远程和资源限制的位置进行实时排序。然而,该技术(这里称为“纳米孔测序”)具有相对高的技术误差率。本研究旨在评估HCV基因组纳米孔测序的效用,准确性和成本效益。我们还介绍了一种新的生物信息工具(Nano-Q),以区分纳米孔测序的主体内变型。纳米孔平台,当覆盖范围超过300读时,产生的可比共识序列对illumina测序。使用HCV包络质粒(〜1800〜NT)以已知的比例混合,纳米孔测序以可靠地鉴定具有大于0.1%的大量的变体的容量,提供了自体参考序列可用于识别匹配读数。来自HCV感染患者的52个样品的成功汇集和纳米孔测序证明了其成本效益(每种样品43美元,纳米孔测序与配对结束短读技术的100美元)。纳米Q工具在宿主序列之间成功分离,包括来自同一亚型的宿主序列,通过本体分选和系统发育聚类而没有自体参考序列(仅使用亚型特定的通用参考)。当适当调整参数时,管道也识别出宿主病毒变体及其丰富。经济高效的HCV全基因组测序和在没有单倍型重建的情况下的宿主变体识别是纳米孔测序的潜在优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号